These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28720522)

  • 1. Patients with non-ambulatory cerebral palsy have higher sclerostin levels and lower bone mineral density than patients with ambulatory cerebral palsy.
    Shin YK; Yoon YK; Chung KB; Rhee Y; Cho SR
    Bone; 2017 Oct; 103():302-307. PubMed ID: 28720522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adults with spastic cerebral palsy have lower bone mass than those with dyskinetic cerebral palsy.
    Kim W; Lee SJ; Yoon YK; Shin YK; Cho SR; Rhee Y
    Bone; 2015 Feb; 71():89-93. PubMed ID: 25316282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density and vitamin D status in ambulatory and non-ambulatory children with cerebral palsy.
    Finbråten AK; Syversen U; Skranes J; Andersen GL; Stevenson RD; Vik T
    Osteoporos Int; 2015 Jan; 26(1):141-50. PubMed ID: 25119201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone density in premenopausal women and men under 50 years of age with cerebral palsy.
    Fowler EG; Rao S; Nattiv A; Heberer K; Oppenheim WL
    Arch Phys Med Rehabil; 2015 Jul; 96(7):1304-9. PubMed ID: 25838020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis in adults with cerebral palsy: feasibility of DXA screening and risk factors for low bone density.
    Marciniak C; Gabet J; Lee J; Ma M; Brander K; Wysocki N
    Osteoporos Int; 2016 Apr; 27(4):1477-1484. PubMed ID: 26576540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy.
    Henderson RC; Lark RK; Gurka MJ; Worley G; Fung EB; Conaway M; Stallings VA; Stevenson RD
    Pediatrics; 2002 Jul; 110(1 Pt 1):e5. PubMed ID: 12093986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal bone mineral density, IGF-1 and IGFBP-3 in children with cerebral palsy.
    Ali O; Shim M; Fowler E; Cohen P; Oppenheim W
    Horm Res; 2007; 68(6):316-20. PubMed ID: 17912004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density.
    Tsentidis C; Gourgiotis D; Kossiva L; Marmarinos A; Doulgeraki A; Karavanaki K
    Pediatr Diabetes; 2016 Jun; 17(4):289-99. PubMed ID: 26094958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus.
    Neumann T; Hofbauer LC; Rauner M; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Hamann C; Sämann A
    Clin Endocrinol (Oxf); 2014 May; 80(5):649-55. PubMed ID: 24237244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study.
    Register TC; Hruska KA; Divers J; Bowden DW; Palmer ND; Carr JJ; Wagenknecht LE; Hightower RC; Xu J; Smith SC; Dietzen DJ; Langefeld CD; Freedman BI
    J Clin Endocrinol Metab; 2014 Jan; 99(1):315-21. PubMed ID: 24178795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients.
    Cejka D; Jäger-Lansky A; Kieweg H; Weber M; Bieglmayer C; Haider DG; Diarra D; Patsch JM; Kainberger F; Bohle B; Haas M
    Nephrol Dial Transplant; 2012 Jan; 27(1):226-30. PubMed ID: 21613383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Densidad mineral ósea e indicadores bioquímicos y hormonales en niños con parálisis cerebral cuadripléjica.
    Álvarez Zaragoza C; Vasquez-Garibay EM; García Contreras AA; Larrosa Haro A; Romero Velarde E; Rea Rosas A; Cabrales de Anda JL; Vega Olea IF
    Nutr Hosp; 2019 Jul; 36(3):517-525. PubMed ID: 30958686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study.
    Plotkin H; Coughlin S; Kreikemeier R; Heldt K; Bruzoni M; Lerner G
    Dev Med Child Neurol; 2006 Sep; 48(9):709-12. PubMed ID: 16904014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone Mineral Density in Adults With Cerebral Palsy.
    Won JH; Jung SH
    Front Neurol; 2021; 12():733322. PubMed ID: 34566876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between vitamin D levels and bone mineral density in patients with multiple sclerosis.
    Triantafyllou N; Lambrinoudaki I; Thoda P; Andreadou E; Kararizou E; Alexandrou A; Limouris G; Antoniou A; Tsivgoulis G
    J Neurol Sci; 2012 Feb; 313(1-2):137-41. PubMed ID: 21992813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low bone mineral density in ambulatory persons with cerebral palsy? A systematic review.
    Mus-Peters CTR; Huisstede BMA; Noten S; Hitters MWMGC; van der Slot WMA; van den Berg-Emons RJG
    Disabil Rehabil; 2019 Oct; 41(20):2392-2402. PubMed ID: 29783868
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density.
    Recker RR; Benson CT; Matsumoto T; Bolognese MA; Robins DA; Alam J; Chiang AY; Hu L; Krege JH; Sowa H; Mitlak BH; Myers SL
    J Bone Miner Res; 2015 Feb; 30(2):216-24. PubMed ID: 25196993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor impairment and skeletal mineralization in children with cerebral palsy.
    Akhter N; Khan AA; Ayyub A
    J Pak Med Assoc; 2017 Feb; 67(2):200-203. PubMed ID: 28138171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral density and nutritional status in children with quadriplegic cerebral palsy.
    Alvarez Zaragoza C; Vasquez Garibay EM; García Contreras AA; Larrosa Haro A; Romero Velarde E; Rea Rosas A; Cabrales de Anda JL; Vega Olea I
    Arch Osteoporos; 2018 Mar; 13(1):17. PubMed ID: 29504042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus.
    Yamamoto M; Yamauchi M; Sugimoto T
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4030-7. PubMed ID: 23894157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.